UK DRI welcomes new Centre Director to UK DRI at Cambridge
We are delighted to announce that Prof Mina Ryten has been appointed as the new Director of the UK DRI Centre at Cambridge University, and Van Geest Professor.
Read moreWe are delighted to announce that Prof Mina Ryten has been appointed as the new Director of the UK DRI Centre at Cambridge University, and Van Geest Professor.
Read moreIn 2022, we launched the UK DRI Biomarker Factory to help find new ways to detect the earliest stages of neurodegenerative disease and monitor its progression in the search for new treatments.
Read moreThe new world-class neuroscience building at UCL, and future home of the UK DRI at UCL and HQ, reached the highest point construction milestone this month, celebrating with a ‘Topping Out’ ceremony on Thursday 11 May.
Read moreWe are delighted to announce that Dr Soyon Hong (UK DRI at UCL) has been awarded the Alzheimer’s Research UK David Hague award for Early Career Investigator of the Year.
Read moreThe Dementia UK Ecosystem (DUKE) brings together leaders from the UK DRI, Dementias Platform UK, the National Institute for Health Research, the pharmaceutical industry, and funders to create a cohesive community, coordinating efforts to accelerate progress in tackling dementia.
Read moreGroup Leader Dr Nir Grossman (UK DRI at Imperial) is leading a new trial using deep electrical currents applied to the brain of people living with Alzheimer's disease. The team are recruiting participants over the next year.
Read moreWe have a clearly defined vision at the UK DRI to develop effective therapeutics, diagnostics and technologies for people living with dementia. Alongside building our disease knowledge over the coming years, we will also make progress in translating these discoveries into the clinic.
Translation and innovationWe accelerate, innovate, deepen and broaden discovery science in dementia, with the goal of filling the huge knowledge gap in this field. We exist to bring forward the day when research benefits people living with and those at risk of dementia.
Read our science visionOur efforts to increase the diversity of our team, ensure inclusion and promote equality of opportunity, align with our vision for the UK DRI’s Institute culture and identity as a world-leader in dementia research.
Equity, Diversity and InclusionWe study a range of neurodegenerative disorders that cause dementia. Many of them share fundamental disease mechanisms and characteristics, and greater understanding gained in one can often benefit others. To ensure we capitalise on diverse expertise, approaches and perspectives, we have established cross-centre themes.
Research themes